Nanyang Biologics

Nanyang Biologics Holdings is a pharma-grade longevity company integrating deep technology with molecular innovation.

We transform nature’s molecular intelligence into scientifically validated therapeutics and longevity solutions, uniting scientific rigour with human purpose to extend lifespan and restore quality of life.

Our Mission

To decode nature’s complexity using AI-driven deep technology, translating molecular insights into scientifically validated therapeutics and longevity solutions.

Nanyang Biologics Holdings

NYB AI

Advances drug discovery through a proprietary AI-led platform inspired by nature.

The platform analyses biological, chemical, and botanical data to accelerate the identification of novel therapeutic leads.

NYB Therapeutics

Develops early-stage therapies guided by biology, data, and nature.

Our programmes focus on metabolic health, inflammation, and oncology.

NYB Nutraceuticals

Develops clinically guided, nature-derived formulations.

Each formulation combines plant-based science, safety, and cultural knowledge to support wellness.

Featured news

Company

Nanyang Biologics Reflects on NVIDIA GTC 2026: A Week of Discovery, Dialogue, and Momentum

NYB at GTC 2026 with valuable scientific exchange, external feedback, and cross-sector dialogue.
Company

Privacy and Security

Privacy and Security Policy of Nanyang Biologics.
Company

Nanyang Biologics to Exhibit at NVIDIA GTC 2026

Nanyang Biologics is pleased to announce that we will be exhibiting at NVIDIA GTC 2026, taking place from March 16–19, 2026.

New Visitor Navigation

New to Nanyang Biologics? Start here to explore our technology, our heritage
and how we transform nature’s wisdom into future healthcare solutions.

If you are looking
for AI drug discovery partners….
If you are looking for nutraceutical distribution partnerships…